[{"id":"28d0bd62-5b35-49f3-a30f-5616172cf246","acronym":"","url":"https://clinicaltrials.gov/study/NCT05263960","created_at":"2022-03-03T14:06:10.705Z","updated_at":"2024-07-02T16:36:09.149Z","phase":"Phase 1/2","brief_title":"A Study of CM350 in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT05263960","lead_sponsor":"Keymed Biosciences Co.Ltd","biomarkers":" GPC3","pipe":" | ","alterations":" GPC3 positive","tags":["GPC3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GPC3 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CM350 • Kangyueda (stapokibart)"],"overall_status":"Recruiting","enrollment":" Enrollment 92","initiation":"Initiation: 04/21/2022","start_date":" 04/21/2022","primary_txt":" Primary completion: 03/01/2025","primary_completion_date":" 03/01/2025","study_txt":" Completion: 03/01/2025","study_completion_date":" 03/01/2025","last_update_posted":"2022-06-09"}]